Humana Inc. (NYSE:HUM) – Analysts at Jefferies Group upped their FY2016 earnings estimates for shares of Humana in a research note issued on Thursday. Jefferies Group analyst D. Windley now forecasts that the firm will post earnings of $9.51 per share for the year, up from their previous forecast of $9.28. Jefferies Group currently has a “Buy” rating and a $217.00 price target on the stock. Jefferies Group also issued estimates for Humana’s FY2017 earnings at $11.40 EPS and FY2018 earnings at $11.51 EPS.
HUM has been the topic of several other research reports. Zacks Investment Research lowered Humana from a “buy” rating to a “hold” rating in a report on Wednesday, September 21st. Royal Bank Of Canada decreased their price objective on Humana from $222.00 to $217.00 and set a “sector perform” rating on the stock in a report on Thursday, October 13th. JPMorgan Chase & Co. lowered Humana from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $196.00 to $150.00 in a report on Friday, July 8th. Evercore ISI started coverage on Humana in a report on Thursday, September 22nd. They set a “buy” rating and a $200.00 price objective on the stock. Finally, Argus reissued a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $200.50.
Humana (NYSE:HUM) opened at 173.27 on Monday. Humana has a 52 week low of $150.00 and a 52 week high of $191.65. The company’s 50-day moving average price is $175.62 and its 200 day moving average price is $175.43. The company has a market cap of $25.83 billion, a PE ratio of 26.62 and a beta of 0.90.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.23 by $0.07. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business earned $14 billion during the quarter, compared to analysts’ expectations of $13.59 billion. During the same quarter last year, the business posted $1.67 earnings per share. The company’s quarterly revenue was up 2.0% on a year-over-year basis.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in HUM. Vanguard Group Inc. boosted its position in Humana by 2.5% in the second quarter. Vanguard Group Inc. now owns 8,964,492 shares of the insurance provider’s stock valued at $1,612,532,000 after buying an additional 219,311 shares during the last quarter. BlackRock Institutional Trust Company N.A. raised its position in shares of Humana by 3.2% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 3,908,027 shares of the insurance provider’s stock valued at $702,976,000 after buying an additional 120,720 shares during the period. Arrowgrass Capital Partners US LP raised its position in shares of Humana by 1.8% in the first quarter. Arrowgrass Capital Partners US LP now owns 2,878,848 shares of the insurance provider’s stock valued at $526,685,000 after buying an additional 51,267 shares during the period. Evercore Trust Company N.A. raised its position in shares of Humana by 3.0% in the second quarter. Evercore Trust Company N.A. now owns 2,570,366 shares of the insurance provider’s stock valued at $462,357,000 after buying an additional 75,126 shares during the period. Finally, BlackRock Fund Advisors raised its position in shares of Humana by 2.5% in the second quarter. BlackRock Fund Advisors now owns 2,074,281 shares of the insurance provider’s stock valued at $373,122,000 after buying an additional 51,378 shares during the period. 93.27% of the stock is currently owned by hedge funds and other institutional investors.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be issued a $0.29 dividend. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 annualized dividend and a dividend yield of 0.67%. Humana’s payout ratio is currently 18.18%.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.